Apteryx Imaging Inc



PE Ratio
Market Cap
52 Week Range
$0.21 - $0.49
Operating Margin
Dividend & Yield
$0 (0.00%)
Rev. per Share

About Apteryx Imaging Inc

Apteryx Imaging Inc. engages in the development and commercialization of dental devices and related software in the United States, Canada, and internationally. Its imaging software products include XrayVision 4 that provides image enhancement and analysis tools with open-architecture technology allowing integration with the imaging systems from various manufacturers; XVWeb, a DICOM server that accepts images from various DICOM-compliant imaging software; XVWeb 3D, a cloud solution for 3D dental imaging; XVlite, a dental imaging software package; and XrayVision DCV, a DICOM-based dental imaging suite. The company's imaging hardware products comprise TUXEDO intraoral sensors; LED IC100 intraoral cameras; and RAYSCAN panoramic + cephalometric imaging solutions. It also offers VELscope Vx system, a device for the enhanced visualization of mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and VELscope Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. Apteryx Imaging Inc. has a partnership agreement with 4th-IR AG to develop cloud-based AI solutions. The company was formerly known as LED Medical Diagnostics Inc. and changed its name to Apteryx Imaging Inc. in September 2019. Apteryx Imaging Inc. was founded in 2002 and is headquartered in Vancouver, Canada. As of August 12, 2020, Apteryx Imaging Inc. operates as a subsidiary of Planet DDS, Inc.


News about Apteryx Imaging Inc

Apteryx Imaging Inc

Health Information Services
About kinfo
Kinfo is an app for DIY traders and investors. Kinfo tracks your trading performance and lets you compare measurable performance metrics against other traders. Kinfo works for day trading, swing trading and longer holding periods. By tracking portfolio performance kinfo allows traders to learn, find inspiration and gain confidence.
Get Social
Download the App

Trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Never risk more than you are willing to lose. Trading futures and other derivatives may cause losses that exceed deposits.

Hypothetical performance results have inherent limitations, some of which are described below. Kinfo makes no representation that any trading account will or is likely to achieve profits or losses like those shown. There are often sharp differences between hypothetical trading performance results and the actual results subsequently achieved by any trading program. Past results of advertised trading systems, profit statements, charts or any other representations are not indicative of future performance.

Kinfo is an educational site and is not a financial adviser or broker. All stocks, ETFs, commodities, Indices, Forex, Bonds, and other securities mentioned in our courses are for educational and illustrative purposes only. If you need professional investment advice, please consult a registered investment adviser. Futures and Options carry risk and may not be suitable for everyone.

Kinfo demonstrates specific advanced approaches (or methods). Any mention of Return of Investment percentages is only indicative of the potential of the strategy or the system and is not meant to signify any guaranteed returns.

Success in trading involves a range of human factors like decision making skills, adjustment skills, emotional control, and risk management and other psychological and behavioral parameters, all of which are completely in the hands of the individual. Trading involves significant risk of loss. It is not suitable for all investors.

Charts on kinfo provided by TradingView